Venous Thromboembolism (PE and DVT) Management in the ED
|
|
- Lorraine Oliver
- 6 years ago
- Views:
Transcription
1 Venous Thromboembolism (PE and DVT) Management in the ED Haldun Akoglu, Assoc. Prof., MD Marmara University Department of Emergency Medicine December, 2014 What is Venous Thromboembolism (VTE)? VTE forms as a result of excessive fibrin production from the action of thrombin on fibrinogen. Factors that enhance fibrinogen synthesis and promote its catalysis to fibrin include Systemic inflammation, Traumatic or immune-related vascular trauma, Inherited thrombophilias and hemoglobinopathies, Cancer, Pregnancy, and Sluggish blood flow. 1
2 What is Venous Thromboembolism (VTE)? Cardinal inciting mechanisms for VTE Venous injury, Slow blood flow, and Hypercoagulability, Most clinical decision rules for VTE incorporate these factors. In addition, each year of life independently increases the likelihood of imbalanced clot formation Deep Vein Thrombosis 2
3 DVT Disease spectrum Minimally symptomatic isolated calf vein thrombosis A limb-threatening iliofemoral venous obstruction. True incidence unknown in the ED population Approx. 600,000 hospital admissions per year Anatomy The venous anatomy of the lower extremity deep system anterior tibial, posterior tibial, peroneal, collectively called the calf veins. popliteal femoral sometimes called superficial femoral. A clot in the superficial femoral is a DVT and should be tx. (superficial) femoral + deep femoral = common femoral External iliac superficial systems greater saphenous short saphenous perforating. Proximal DVT = clot in the popliteal vein or higher, Distal DVT = clot isolated to calf veins. 3
4 Clinical Presentation Can be as subtle and nonspecific as a mild cramping sensation or sense of fullness in the calf, w/o objective swelling, and may be difficult to differentiate clinically from myriad other, unrelated disorders. Many patients use the term charley horse to describe the sensation of an early DVT (painful spasms and cramps in the leg muscles). It is precisely at this early stage, however, that DVT can be treated most effectively to minimize the potential morbidity and mortality associated with VTE. 4
5 Clinical Presentation Because the left iliac vein is vulnerable to compression by the left iliac artery, leg DVT occurs with a slightly higher frequency in the left leg Bilateral leg DVT < 10% of ED patients diagnosed with DVT. Clinical Presentation Clinical signs of DVT unilateral swelling, edema, erythema, warmth; tenderness to palpation along the distribution of the deep venous system; dilation of superficial collateral veins; palpable venous cord. 5
6 Clinical Presentation Homan s sign pain felt in the calf or posterior aspect of the knee on passive dorsiflexion of the foot while the knee is extended is insensitive and nonspecific for DVT has no role in clinical assessment of the patient. Clinical Presentation Upper extremity DVT thrombosis in the axillary vein causes arm swelling on the same side as an indwelling catheter or recent intravenous infusion site. In the absence of a catheter, the most frequent location of arm DVT is on the dominant hand side. Patients frequently note that their rings become tight as an early sign of DVT 6
7 Diagnosis Diagnosis of DVT and PE starts with an estimation of the pretest probability (PTP). This estimation may be accomplished either by the clinical gestalt of an experienced practitioner or in conjunction with a clinical decision tool, such as that derived and validated by Wells and colleagues Patients with a low PTP can have DVT excluded with a normal quantitative D-dimer Lab D-dimer protein derived from enzymatic breakdown of crosslinked fibrin, an elevated plasma concentration indicates the presence of a clot formed somewhere in the body within the previous 72 hours. concentration is proportionate to the size of the clot and decreases as the clot matures, so the test is less sensitive with small or chronic clots 7
8 Lab D-dimer concentration may be elevated with any condition that causes fibrin deposition, malignancy, pregnancy, advanced age, prolonged bed rest, recent surgery, infection, inflammation, new indwelling catheters, stroke, myocardial infarction. D-Dimer Assays The D-dimer protein can be measured in plasma with several techniques, and the differences in D-dimer assay methodology greatly affect diagnostic accuracy. 75 different d-dimer assays approved by FDA 2 major types: Qualitative Quantitative ELISA Immunoturbidimetric 8
9 D-Dimer Assays For many assays, less than 500 ng/ml (or 1000 fibrinogen equivalent units ([FEUs]) is a negative test result carries an 88 to 97% diagnostic sensitivity for symptomatic proximal DVT 83 to 94% sensitivity for calf DVT or asymptomatic proximal DVT. A negative quantitative D-dimer assayed by the ELISA or immunoturbidimetric technique is sensitive enough to exclude the diagnosis of DVT in patients at low or moderate risk without further evaluation. 9
10 Radiographic Evaluation DVT evaluation is by a combination of D-dimer testing Duplex venous USG by an expert. 3-point sequence (common and superficial femoral veins and popliteal vein, excluding the calf and saphenous veins) USG Sens & Spec 95% for proximal DVT The diagnostic test of choice in most centers. Dx Sens of a SINGLE venous USG for the exclusion of a clot at risk of progressing to a proximal DVT is increased significantly by including the calf and saphenous veins Radiographic Evaluation Low risk (PTP) pt + Neg 3-point USG = R/O DVT Any risk (PTP) pt + single normal whole-leg USG (including normal calf and saphenous veins) = R/O DVT Any risk (PTP) pt + Neg 3-point USG + Neg quant. D-dimer = R/O DVT Higher than low risk (PTP) pt + Neg 3-point USG = inadequate as a sole method to exclude DVT High risk (PTP) pt + High/No D-Dimer + Neg 3-point USG = repeat USG in 2 to 7 days, if negative R/O PE. Pos 3-point USG = DVT 10
11 Radiographic Evaluation Indirect CT venography (CTV) is not a primary imaging modality for DVT May be performed in conjunction with CT pulmonary angiography (CTPA) of the chest during the evaluation of suggested PE. CTV + CTPA: incremental increase in the Sens for VTE, identifying DVT in approximately 2% of patients in whom the CTPA is read as negative for PE but at the expense of significant additional radiation exposure to the pelvis and lower extremities. Routine use of CTV is not necessary when CTPA is performed Treatment When the diagnosis of DVT has been established, anticoagulation should be initiated, unless contraindicated, with a low-molecular-weight heparin (e.g., enoxaparin 1 mg/kg subcutaneously [SQ] every 12 hours), fondaparinux (5-10 mg SQ once daily, depending on patient weight), or unfractionated heparin (70-80 units/kg IV bolus followed by units/kg/hr infusion), assuming normal renal function The treatments work equally well and are safe in the absence of contraindications to anticoagulation. 11
12 Treatment Treatment requires transition to oral anticoagulation with warfarin for at least 3 months. Patients should be encouraged to ambulate after anticoagulation for DVT. Bed rest promotes DVT extension, increases the risk of embolization, and ultimately predisposes the patient to the postphlebitic syndrome. Patients who cannot be given anticoagulants or who have a recurrence of VTE despite anticoagulation therapy should be considered for vena caval intervention. Tx - Superficial Leg Thrombophlebitis Clot in the greater saphenous vein that extends above the knee are at risk for progression to DVT = anticoagulation. Saphenous vein thrombophlebitis tx NSAIDs, heat, graded compression stockings (fitted to exert mm Hg of pressure at the ankle) a mandatory repeat USG in 2 to 5 days. If the clot is extending, then anticoagulation is indicated. full-dose LMWH or fondaparinux for 10 days followed by repeat USG. 12
13 Tx - Isolated Calf Vein Thrombosis Tibial or peroneal vein thrombosis in an otherwise healthy, ambulatory pt with no other indication for anticoagulation Aspirin (325 mg of enteric-coated per day) Close follow-up with repeat USG at 2 to 5 days 25% of isolated calf vein thromboses propagate proximally = Tx w anticoagulation as for proximal DVT. Tx - Phlegmasia Cerulea Dolens (Painful Blue Leg) Massive iliofemoral occlusion results in swelling of the entire leg with extensive vascular congestion and associated venous ischemia, producing a painful, cyanotic extremity. There may be an associated arterial spasm resulting in phlegmasia alba dolens (painful white leg or milk leg), which may mimic an acute arterial occlusion. Consultation with a vascular surgeon for emergent thrombectomy evaluation. If timely consultation is not possible, early thrombolytic therapy in the absence of contraindications. Alteplase (1 mg/min to a total dose of 50 mg) via a peripheral IV catheter distal to the thrombus 13
14 Tx - Upper Extremity Venous Thromboses Etio use of indwelling venous catheters (50%) wires for electronic cardiac devices Upper extremity DVT can cause PE, and all patients with DVT above the elbow require definitive treatment Dx & R/O w venous USG. Value of D-dimer?? Tx - Upper Extremity Venous Thromboses UE DVT(+) + NO pain or infection Does NOT automatically warrant catheter removal if the catheter serves a current, vital purpose. Give anticoagulation if they do not have contraindications. Anticoagulate for at least 3 months after catheter removal 14
15 Complications Most feared complication of DVT is fatal PE DVT damages venous valves, causing venous insufficiency. painless varicosities to severe postphlebitic syndrome unremitting pain and swelling, varicose veins, skin changes, and nonhealing ulcers. 15
16 Q & Pulmonary Embolism 16
17 Pulmonary Embolism Clot that formed hours, days, or weeks earlier in the deep veins and dislodged, traveled through the venous system, and traversed the RV into the pulmonary vasculature. Symptoms vary from no symptom to CV collapse. About 8% of ED patients with PE die within 30 days, even when PE is promptly diagnosed and treated Pathophysiology of Pulmonary Vascular Occlusion Young persons w/o CV disease tolerate at least 30% obstruction, often with minimal symptoms or signs. Clot lodged deeply in a segmental artery (1/16 of all) can obstruct blood flow to a sufficient degree to cause tissue necrosis. Focal, sharp, pleuritic pain Over several days the infarcted segment becomes consolidated on CXR and exudes a pleural effusion, Chest pain from noninfarcting PE can be highly variable and vague. About 30% of patients with definite PE have no perception of chest pain. 17
18 Pathophysiology of Pulmonary Vascular Occlusion 90% of pts w non-infarcting emboli have sensation of dyspnea. Dyspnea may be constant and oppressive or may be intermittent and perceived only with exertion. Pathophysiology of Pulmonary Vascular Occlusion 15% of pts w PE have a normal A-a gradient of oxygen normal defined as age in years/4 + 4 A-a gradient is abnormally high in most pts who are evaluated for PE but ultimately found to not have PE. Presence of hypoxemia (pulse oximetry <95%, breathing room air) that cannot be explained by a known disease process increases the probability of PE. A normal oxygen saturation can NOT R/O PE. 18
19 Pathophysiology of Pulmonary Vascular Occlusion 50% patients with PE have HR > 100 beats/min. In one study, the probability of PE was not reduced in patients who normalized any vital sign while in the ED. Arterial hypotension: ominous hemodynamic consequence of PE; it occurs in only about 10% of patients but signifies a fourfold increase in risk of death Pulseless electrical activity (PEA) is the most common electrocardiogram (ECG) result from obstructive PE. The survival rate for cardiac arrest from PE is abysmally low, even if the arrest is witnessed and heroic treatment is initiated Clinical Presentation Variables that increase the probability of PE in epidemiologic studies are not useful for individual ED patients with signs and symptoms suggesting PE. From an epidemiologic standpoint, people who smoke are at a significantly higher risk for venous clots than are people who do not smoke. However, in the ED, smoking by a given patient does not seem to increase that person s risk for PE over that of a nonsmoker with an otherwise identical clinical presentation. 50% of patients diagnosed with PE have no apparent clinical risk factors for VTE. 19
20 Clinical Presentation Any ED visit rel d to weakness, SoB, dizziness or syncope, pain, extremity discomfort, or nonspecific malaise or functional deterioration could represent a potential PE. This does not mean that every pt w one of these sx should be worked up for PE. Consider Sx in the context of the entire clinical picture. A typical patient with PE Presents with 2 to 3 days of SoB, now worsened. Chest pain is vaguely described. A few pts have focal pleuritic chest pain, Many say that their chest hurts with breathing on lateral. Purely substernal chest pain is rare and suggests cardiac The presence or absence of sudden onset of symptoms neither increases nor decreases the probability of PE. 20
21 Clinical Presentation From antemortem histories of patients who die suddenly and unexpectedly from PE most have complained of nagging symptoms for weeks before collapse, 40% already had seen a physician for care. PE with lung infarction Clinical picture similar to lobar pneumonia, (focal chest pain, fever, and unilateral rales on auscultation). Temperature greater than 38,6 C suggests infection In pulmonary infarction onset of pain and blood-red hemoptysis are on the same day, In lobar pneumonia productive cough is present for a few days before rust-tinged sputum Clinical Presentation PExam Unilateral leg asymmetry (DVT) Jugular venous distention in a pt w severe dyspnea and clear lung fields on auscultation = pure RV failure. Wheezing suggests bronchospasm, which is not common in PE and makes the diagnosis less likely (but does not exclude it). Bilateral rales suggest LV failure, although localized rales often are heard over infarcted lung tissue. 21
22 Diagnosis CXR: Suggest alternative Dx (Pnem, CHF, PTX) Unilat basilar atelectasis prob of PE Hampton s Hump Apex-cental, pleure-based, wedge-shaped infiltrate Westermark s sign Unilateral lung oligemia very rare and only in large PE Diagnosis EKG Alternative Dx (pericarditis, AMI) PE EKG findings are due to scute or subacute pulm HTN Tachycardia Symm T-inversion V1-4 McGinn-White S1Q3T3 pattern Incomplete/Complete RBBB Each doubles prob of PE in Sx ic Pts 22
23 Approach to the Dx Strategy of PE 50% of patients diagnosed with PE have no identifiable classic risk factors Currently EPs evaluate 1-2% of all patients for PE Each year more than 16 million patients come to the ED with chest pain or dyspnea. Although numerous cases of PE are probably still missed, overtesting for PE can also be harmful. There is a risk of false-positive interpretation of CTPA, which may occur in as many as 10% of scans read as positive for PE So, there should be a rational, reproducible strategy to guide the decision-making and diagnostic processes 23
24 Approach to the Dx Strategy of PE This strategy should begin with estimation of PTP. Methods for estimating PTP can be implicit (meaning the clinician s best guess) or explicit (meaning use of a scoring system or flow algorithm to categorize the probability) Approach to the Dx Strategy of PE One approach to the workup for PE is to compare the PTP with the test threshold for PE. The test threshold represents the point above which some type of workup should be initiated and below which the clinician can justify not starting the workup. For PE the test threshold is 1 to 2.5%. Patients with a PTP less than 2.5% are more likely to be harmed than benefited by a workup and vice versa for patients with a PTP greater than 2.5% The question becomes how to quantify the PTP accurately. 24
25 Approach to the Dx Strategy of PE Clinical judgment alone is subject to cognitive error inherent to medical diagnosis, framing heuristic conditions in the ED at the time (e.g., is one less likely to pursue a relatively low-likelihood diagnosis when the department is very busy), conditions of the clinician (e.g., fatigue, dysphoria, subjective feelings about the patient), availability of diagnostic studies (e.g., daytime vs. nighttime, weekday vs. weekend). In addition, there is variability among clinicians who may not agree that a 19-year-old with cough and pleuritic chest pain, a normal CXR, and no other risk factors has less than a 2% probability of PE Decision rules help to deal with these problems because they are structured and more transparent. 25
26 Approach to the Dx Strategy of PE Although gestalt reasoning and clinical decision rules may provide adequate stratification to guide the workup (i.e., D-dimer vs. pulmonary vascular imaging), they have not been able to reproducibly identify the very low-risk population whose PTP lies below the 2% test threshold To identify the very low-risk group in whom PE could be safely excluded at the bedside with no diagnostic testing, the PE rule-out criteria (the PERC rule) were derived When the physician s unstructured clinical suspicion for PE is low and each of the eight elements of the rule is satisfied, the PERC rule identifies a very low-risk population among whom no patient has a PTP for PE of greater than 2%. In the large validation series, the rule excluded PE at the bedside in 20% of cases and yielded a false-negative rate of 1% (95% confidence interval [CI] %). Patients with risk factors but w/o any sx/signs of PE (e.g., no chest pain, SoB, dyspnea on exertion, normal vitas, no syncope) DO NOT warrant workup for PE unless there is some compelling clinical indication. 26
27 Algorithm w CTA For a patient for whom suspicion is implicit or with explicit score suggesting a PTP over 40%, clinicians should skip the D- dimer, order pulmonary vascular imaging, and strongly consider initiating anticoagulation in the absence of contraindications. Because the half-life of circulating D-dimer is less than 8 hours, the sensitivity of the D-dimer may decrease if the patient s symptoms have been present for longer than 3 days. False-negative D-dimer measurements may also be seen with ongoing warfarin therapy and in the subset of patients with pulmonary infarction. Algorithm w V/Q * May require patient admission. Additional testing Option 1: Crossover to perform scanning or CT for algorithms A and B. Option 2: Perform lower extremity venous USG, and if initial venous USG is negative, repeat in 1 week. Option 3: Perform formal pulmonary angiography. 27
28 Subsegmental Embolism in CTPA It is reasonable that if the patient has no evidence of DVT, no signs of cardiopulmonary stress, no ongoing major risk for thrombosis (e.g., active malignancy), isolated subsegmental findings are the equivalent of no findings, and anticoagulation is not indicated. 28
29 Management - Anticoagulation Unfractionated heparin (80 units/kg intravenous bolus, followed by 18 units/kg/hr intravenous infusion), Fractionated LMWH (e.g., enoxaparin, 1 mg/kg SQ or intravenously [IV] every 12 hours), pentasaccharide factor Xa inhibitor fondaparinux (5-10 mg, depending on body mass) can be used for treatment of most patients with PE. Side Effects of LMWH << UFH But, reversal agent Protamine Sulfate reverses UFH 100%, LMWH 50%, fondaparinux 0% Fact All patients with A high PTP, No contraindication to anticoagulation, evidence of hemodynamic instability, recent syncope, hypotension, hypoxemia, clinical evidence of RV heart strain (more severe moderate PE or high-risk PE) should receive immediate empirical heparin. 29
30 Fact For a patient diagnosed with PE in the presence of a major contraindication to anticoagulation, (recent cerebral hemorrhage or large cerebral infarction) consultant should be contacted for urgent placement of an inferior vena cava filter. If vena caval interruption cannot be performed within 12 hours, perform a baseline head CT scan, then start UFH infusion at 18 units/kg/hr (without a bolus) admit the patient to the ICU for close neurologic monitoring and frequent PTT. The rationale for use of UFH is that it can be reversed more reliably (by discontinuing the heparin drip and administering protamine, 1 mg/kg IV) Thrombolytics Thrombolytic therapy in PE is controversial. Alteplase results in more rapid symptomatic improvement than standard antithrombotic therapy alone and causes more rapid and complete normalization of RV function. Alteplase also increases the risk of hemorrhage, especially minor hemorrhage It is not known with certainty how many patient lives would be saved, or definitively improved, by the addition of thrombolytic treatment to heparin therapy versus the number of patients who would experience a fatal or lifethreatening bleeding event as a result of thrombolytic treatment. Benefit-risk analysis suggests that fibrinolysis is of greatest value in the subset of patients with proven, massive PE. 30
31 Thrombolytics and Massive PE Massive PE is defined as, hypotension with a SBP < 90 mm Hg for more than 15 min In patients with preexisting HT, SBP < 100 mm Hg or a reduction in the baseline SBP > 60 mm Hg. In the absence of contraindications, patients with proven massive PE probably benefit from fibrinolysis. There is insufficient evidence to recommend initiation of empirical fibrinolysis in the absence of confirmatory pulmonary vascular imaging or the presence of otherwise unexplained shock in a patient with known DVT and high clinical suspicion for PE. Thrombolytics and Submassive PE A subset of patients with submassive PE may benefit from fibrinolysis, those with moderate-to-severe respiratory distress and hypoxia (oxygen saturation less than 95%) and, those with Echo evidence of RV dysfunction. If Echo not available laboratory markers of RV dysfunction may be useful, elevated TnI level or BNP > 90 pg/ml. 31
32 Unique Questions That Commonly Arise in the Emergency Department I cannot get imaging at night. Is it reasonable to treat the patient with heparin until morning? The short answer to this question is yes, if the patient has no contraindications. Many smaller hospitals routinely use this method and use a single dose of enoxaparin. 32
33 How do I manage the patient who is being treated for pulmonary embolism who returns to the ED for chest pain? If the patient has a therapeutic INR ( ) and returns with symptoms only (e.g., chest pain, dyspnea) and without syncope, appears relatively comfortable, has normal vital signs, and has no new changes suggesting Pulm HTN on ECG (in particular, no S1Q3T3 pattern and no T wave inversion in leads V1 through V4), follow-up imaging is probably not needed. Other causes of chest pain (esp ACS) should be considered How can I rule out pulmonary embolism in a pregnant patient without use of ionizing radiation? One clinical conundrum is the fact the pregnancy is accompanied by both an increased risk of PE and a predictable elevation in D-dimer, even in the absence of PE. Given that PE is the most common nontraumatic cause of death in pregnant women, clinicians are justified in adopting a liberal rule-out PE approach to all pregnant women with dyspnea. 33
34 How can I rule out pulmonary embolism in a pregnant patient without use of ionizing radiation? First, assess the PERC rule criteria and apply a modified version of the PERC rule with a slightly elevated top limit for the pulse rate (normal up to 104 beats/min instead of 99 beats/min). If the result of this modified PERC rule is negative, then order a quantitative D-dimer. Use thresholds to define a normal D-dimer that is elevated on the basis of trimester (first trimester, 1.5 ; second trimester, 2 ; and third trimester, 2.5 standard threshold). If the result of the modified PERC rule is positive or the D- dimer is above the adjusted threshold, then order bilateral lower extremity ultrasound; if this is positive for DVT, then treat for PE. If the bilateral ultrasound is negative, proceed to pulmonary vascular imaging. How can I rule out pulmonary embolism in a pregnant patient without use of ionizing radiation? The issue of the optimal imaging procedure in pregnancy remains controversial. A 2003 survey of radiologists indicated an almost equal split (53% in favor of CTPA, 47% in favor of V/Q scanning) in their choice for imaging for PE in pregnancy. A plain film CXR be taken first, and if CXR shows no air space disease, that Q scan can be considered only the perfusion phase, the radiation dose is halved. Give prehydration, place a Foley catheter to accelerate removal of radiolabel in the bladder. If the CXR has evidence of airspace disease, CTPA should be performed and abdomen should be shielded. If Q scan negative = R/O PE N CXR perfusion defects = PE = UFH If Q scan non-diagnostic = CTPA 34
35 How do I evaluate the patient with possible pulmonary embolism who is too obese to fit in a CT scanner? Duplex USG of the lower extremities to R/O DVT. If positive = PE Another option is to anticoagulate empirically based on a moderate-to-high pretest probability and a D- dimer concentration that exceeds 1000 ng/ml. The adequate regimen for anticoagulation is uncertain, but many experts recommend SC enoxaparin, 1 mg/kg of actual body weight up to a maximum of 200 µg/kg. Q & haldun.akoglu@marmara.edu.tr 35
Dr. Rami M. Adil Al-Hayali Assistant Professor in Medicine
Dr. Rami M. Adil Al-Hayali Assistant Professor in Medicine Venous thromboembolism: pulmonary embolism (PE) deep vein thrombosis (DVT) 1% of all patients admitted to hospital 5% of in-hospital mortality
More informationPE and DVT. Dr Anzo William Adiga WatsApp or Call Medical Officer/RHEMA MEDICAL GROUP
PE and DVT Dr Anzo William Adiga WatsApp or Call +256777363201 Medical Officer/RHEMA MEDICAL GROUP OBJECTIVES DEFINE DVT AND P.E PATHOPHYSIOLOGY OF DVT CLINICAL PRESENTATION OF DVT/PE INVESTIGATE DVT MANAGEMENT
More informationPULMONARY EMBOLISM (PE): DIAGNOSIS AND TREATMENT
PULMONARY EMBOLISM (PE): DIAGNOSIS AND TREATMENT OBJECTIVE: To provide a diagnostic algorithm and treatment options for patients with acute pulmonary embolism (PE). BACKGROUND: Venous thromboembolism (VTE)
More informationVenous thrombosis is common and often occurs spontaneously, but it also frequently accompanies medical and surgical conditions, both in the community
Venous Thrombosis Venous Thrombosis It occurs mainly in the deep veins of the leg (deep vein thrombosis, DVT), from which parts of the clot frequently embolize to the lungs (pulmonary embolism, PE). Fewer
More informationPulmonary Embolism. Pulmonary Embolism. Pulmonary Embolism. PE - Clinical
Pulmonary embolus - a practical approach to investigation and treatment Sam Janes Wellcome Senior Fellow and Respiratory Physician, University College London Background Diagnosis Treatment Common: 50 cases
More informationThrombolysis in PE. Outline. Disclosure. Overview on Pulmonary Embolism. Hot Topics in Emergency Medicine 2012 Midyear Clinical Meeting
Disclosure Thrombolysis in PE Daniel P. Hays, PharmD, BCPS, FASHP reports no relevant financial relationships. Daniel P. Hays, PharmD, BCPS, FASHP Outline 55 YOF presents to ED with SOB PMH of DVT + noncompliance
More informationPulmonary Thromboembolism
Pulmonary Thromboembolism James Allen, MD Epidemiology of Pulmonary Embolism 1,500,000 new cases per year in the United States Often asymptomatic 300,000 deaths per year DVT or PE present in 10% of ICU
More informationOctober 2017 Pulmonary Embolism
October 2017 Pulmonary Embolism Prof. Ahmed BaHammam, FRCP, FCCP Professor of Medicine College of Medicine King Saud University 1 Objectives Epidemiology Pathophysiology Diagnosis Massive PE Treatment
More informationEpidemiology. Update on Pulmonary Embolism. Keys to PE Management 5/5/2014. Diagnosis. Risk stratification. Treatment
Update on Pulmonary Embolism Steven M. Dean, DO, FACP, RPVI Program Director- Vascular Medicine Associate Professor of Internal Medicine Division of Cardiovascular Medicine The Ohio State University Keys
More informationDisclosures. DVT: Diagnosis and Treatment. Questions To Ask. Dr. Susanna Shin - DVT: Diagnosis and Treatment. Acute Venous Thromboembolism (VTE) None
Disclosures DVT: Diagnosis and Treatment None Susanna Shin, MD, FACS Assistant Professor University of Washington Acute Venous Thromboembolism (VTE) Deep Venous Thrombosis (DVT) Pulmonary Embolism (PE)
More informationRisk factors for DVT. Venous thrombosis & pulmonary embolism. Anticoagulation (cont d) Diagnosis 1/5/2018. Ahmed Mahmoud, MD
Risk factors for DVT Venous thrombosis & pulmonary embolism Ahmed Mahmoud, MD Surgery ; post op especially for long cases, pelvic operations (THR), Trauma ; long bone fractures, pelvic fractures (posterior
More informationVenous thrombosis & pulmonary embolism. Ahmed Mahmoud, MD
Venous thrombosis & pulmonary embolism Ahmed Mahmoud, MD Risk factors for DVT Surgery ; post op especially for long cases, pelvic operations (THR), Trauma ; long bone fractures, pelvic fractures (posterior
More informationJessica Bryan, Natalia Evans, Karlyn Henderson, & Whitney Parks
Jessica Bryan, Natalia Evans, Karlyn Henderson, & Whitney Parks 1. What is the most common cause of death in hospitalized patients? 1. Hospital-acquired infection 2. Pulmonary embolism 3. Myocardial infarction
More informationMabel Labrada, MD Miami VA Medical Center
Mabel Labrada, MD Miami VA Medical Center *1-Treatment for acute DVT with underlying malignancy is for 3 months. *2-Treatment of provoked acute proximal DVT can be stopped after 3months of treatment and
More informationVenous Thrombosis. Magnitude of the Problem. DVT 2 Million PE 600,000. Death 60,000. Estimated Cost of VTE Care $1.5 Billion/year.
Venous Thrombosis Magnitude of the Problem DVT 2 Million Postthrombotic Syndrome 800,000 PE 600,000 Death 60,000 Silent PE 1 Million Pulmonary Hypertension 30,000 Estimated Cost of VTE Care $1.5 Billion/year
More informationJordan M. Garrison, MD FACS, FASMBS
Jordan M. Garrison, MD FACS, FASMBS Peripheral Arterial Disease (PAD) Near or Complete obstruction of > 1 Peripheral Artery Peripheral Venous reflux Disease Varicose Veins Chronic Venous Stasis Ulcer Disease
More informationProper Diagnosis of Venous Thromboembolism (VTE)
Proper Diagnosis of Venous Thromboembolism (VTE) Whal Lee, M.D. Seoul National University Hospital Department of Radiology 2 nd EFORT Asia Symposium, 3 rd November 2010, Taipei DVT - Risk Factors Previous
More informationAcute Pulmonary Embolism and Deep Vein Thrombosis. Barbara LeVarge MD Beth Israel Deaconess Medical Center Pulmonary Hypertension Center COPYRIGHT
Acute Pulmonary Embolism and Deep Vein Thrombosis Barbara LeVarge MD Beth Israel Deaconess Medical Center Pulmonary Hypertension Center Acute PE and DVT No disclosures. Acute PE and DVT Learning objectives
More informationDeep Vein Thrombosis and Pulmonary Embolism: Patient Information
Deep Vein Thrombosis and Pulmonary Embolism: Patient Information A Deep Vein Thrombosis (DVT) and a Pulmonary Embolism (PE) are both disorders of unwanted blood clotting. Unwanted blood clots can occur
More informationDiagnosis of Venous Thromboembolism
Diagnosis of Venous Thromboembolism An Educational Slide Set American Society of Hematology 2018 Guidelines for Management of Venous Thromboembolism Slide set authors: Eric Tseng MD MScCH, University of
More informationClinical Guide - Suspected PE (Reviewed 2006)
Clinical Guide - Suspected (Reviewed 2006) Principal Developer: B. Geerts Secondary Developers: C. Demers, C. Kearon Background Investigation of patients with suspected pulmonary emboli () remains problematic
More informationPulmonary Embolism. Thoracic radiologist Helena Lauri
Pulmonary Embolism Thoracic radiologist Helena Lauri 8.5.2017 Statistics 1-2 out of 1000 adults annually are diagnosed with deep vein thrombosis (DVT) and/or pulmonary embolism (PE) About half of patients
More informationCURRENT & FUTURE THERAPEUTIC MANAGEMENT OF VENOUS THROMBOEMBOLISM. Gordon Lowe Professor of Vascular Medicine University of Glasgow
CURRENT & FUTURE THERAPEUTIC MANAGEMENT OF VENOUS THROMBOEMBOLISM Gordon Lowe Professor of Vascular Medicine University of Glasgow VENOUS THROMBOEMBOLISM Common cause of death and disability 50% hospital-acquired
More informationPULMONARY EMBOLISM -CASE REPORT-
University Goce Delcev, Faculty of Medical sciences, Stip University Clinic of Cardiology, Skopje R. Of Macedonia PULMONARY EMBOLISM -CASE REPORT- Gordana Kamceva MD mr.sci Acknowledgment Marija Vavlukis
More informationDEEP VEIN THROMBOSIS (DVT): TREATMENT
DEEP VEIN THROMBOSIS (DVT): TREATMENT OBJECTIVE: To provide an evidence-based approach to treatment of patients presenting with deep vein thrombosis (DVT). BACKGROUND: An estimated 45,000 patients in Canada
More informationSlide 1. Slide 2. Slide 3. Outline of This Presentation
Slide 1 Current Approaches to Venous Thromboembolism Prevention in Orthopedic Patients Hujefa Vora, MD Maria Fox, RN June 9, 2017 Slide 2 Slide 3 Outline of This Presentation Pathophysiology of venous
More informationLearning Objectives for Rotations in Vascular Surgery Year 3 Basic Clerkship
Learning Objectives for Rotations in Vascular Surgery Year 3 Basic Clerkship CLINICAL PROBLEMS IN VASCULAR SURGERY 1. ABDOMINAL AORTIC ANEURYSM A 70 year old man presents in the emergency department with
More informationREVIEW ON PULMONARY EMBOLISM
REVIEW ON PULMONARY EMBOLISM * Shashi Kumar Yadav, Prof. Xiao Wei, Roshan Kumar Yadav, Sanjay Kumar Verma and Deepika Dhakal * Department of Medicine, Clinical College of Yangtze University, The first
More informationDiagnosis and Treatment of Deep Venous Thrombosis and Pulmonary Embolism
Agency for Healthcare Research and Quality Evidence Report/Technology Assessment Diagnosis and Treatment of Deep Venous Thrombosis and Pulmonary Embolism Summary Number 68 Overview Venous thromboembolism
More informationObjectives. Venous Thromboembolism (VTE) Prophylaxis. Case VTE WHY DO IT? Question: Who Is At Risk?
Objectives Venous Thromboembolism (VTE) Prophylaxis Rishi Garg, MD Department of Medicine Identify patients at risk for VTE Options for VTE prophylaxis Current Recommendations (based on The Seventh ACCP
More informationSurgical approach for DVT. Division of Vascular Surgery Department of Surgery Seoul National University College of Medicine
Surgical approach for DVT Seung-Kee Min Division of Vascular Surgery Department of Surgery Seoul National University College of Medicine Treatment Options for Venous Thrombosis Unfractionated heparin &
More informationDVT and Pulmonary Embolus. Dr Piers Blombery BSc(Biomed), MBBS (Hons), FRACP, FRCPA Consultant Haematologist Peter MacCallum Cancer Centre
DVT and Pulmonary Embolus Dr Piers Blombery BSc(Biomed), MBBS (Hons), FRACP, FRCPA Consultant Haematologist Peter MacCallum Cancer Centre Overview Structure of deep and superficial venous system of upper
More informationVenous thromboembolic diseases: diagnosis, management and thrombophilia testing (2012) NICE guideline CG144
Venous thromboembolic diseases: diagnosis, management and thrombophilia testing (2012) NICE guideline CG144 Appendix A: Summary of new evidence from Summary of evidence from previous year Diagnosis Diagnostic
More informationMATERIALS AND METHODS
RETROSPECTIVE STUDY OF OPTIMISING THE USE OF COMPUTED TOMOGRAPHY PULMONARY ANGIOGRAPHY (CTPA) FOR THE DIAGNOSIS OF PULMONARY EMBOLISM IN PLACES WITH LIMITED RESOURCES P. V. Kalyan Kumar 1, Ramakrishna
More informationCHAPTER 2 VENOUS THROMBOEMBOLISM
CHAPTER 2 VENOUS THROMBOEMBOLISM Objectives Venous Thromboembolism (VTE) Prevalence Patho-physiology Risk Factors Diagnosis Pulmonary Embolism (PE) Management of DVT/PE Prevention VTE Patho-physiology
More informationJeffrey Tabas, MD. sf g h. Risk Assessment Do we understand risk stratification? Are we limiting radiation /contrast with the PERC rule and D-Dimers?
Pulmonary Embolism Update Jeffrey Tabas, MD Professor UCSF School of Medicine Emergency Department San Francisco General Hospital Disclosure No Financial Relationships to Disclose No significant investments
More informationPulmonary Thromboembolism
Pulmonary Thromboembolism Jing ZHANG ( 张静 ), MD, PhD zhang.jing@zs-hospital.sh.cn Department of Pulmonary Medicine Zhongshan Hospital Fudan University OUTLINE Understand the historical context of pulmonary
More informationSingle Center 4 year series of 114 consecutive patients treated for massive and submassive PE. Mark Goodwin, MD
Single Center 4 year series of 114 consecutive patients treated for massive and submassive PE Mark Goodwin, MD Disclosure Speaker name:... I have the following potential conflicts of interest to report:
More informationEpidemiology: Incidence VTE: Mortality Morbidity Risk Factors: Acute Chronic : Genetic
Submassive PE Pulmonary Embolism Epidemiology: Incidence VTE: 100-200/100,000 = 3rd most frequent cardiovascular disease Symptomatic DVT complicated by PE = 40-50% Sudden fatal PE = 34% Intermediate-risk
More informationDVT - initial management NSCCG
Background information Information resources for patients and carers Updates to this care map Synonyms Below knee DVT and bleeding risks Patient with confirmed DVT Scan confirms superficial thrombophlebitis
More informationIVC FILTERS: A CASE REPORT REVIEWING THE INDICATIONS FOR PLACEMENT, RETRIEVAL AND ANTICOAGULATION
IVC FILTERS: A CASE REPORT REVIEWING THE INDICATIONS FOR PLACEMENT, RETRIEVAL AND ANTICOAGULATION Resident(s): George Athanasatos Attending(s): Daniel Golwyn Program/Dept: Interventional Radiology CHIEF
More informationWhat s New in DVT & PE
What s New in DVT & PE Mark Buch MD CM CCFP(EM) Attending physician Emergency Department Jewish General Hospital Family Physician and Medical Director GMF Santé Mont-Royal Objectives: Review the diagnostic
More informationPE Pathway. The charts are listed as follows:
PE Pathway This document comprises 6 simple flow charts to assist clinicians in the investigation and treatment of suspected or confirmed Acute Pulmonary Emboli. The pathway has been put together using
More informationCover Page. The handle holds various files of this Leiden University dissertation.
Cover Page The handle http://hdl.handle.net/1887/21764 holds various files of this Leiden University dissertation. Author: Mos, Inge Christina Maria Title: A more granular view on pulmonary embolism Issue
More informationSuspected Deep Vein Thrombosis (DVT) Pathway for Non Pregnant patients Updated November 2016, with new D-dimer reference range
Suspected Deep Vein Thrombosis (DVT) Pathway for Non Pregnant patients Updated November 2016, with new D-dimer reference range Suspect a DVT? Complete a Two-level DVT Wells score on ICE system (see page
More informationDeep Vein Thrombosis
Deep Vein Thrombosis Introduction Deep vein thrombosis (DVT) is a blood clot in a vein. This condition can affect men and women of any age and race. DVT is a potentially serious condition. If not treated,
More informationVENOUS THROMBOEMBOLISM DR. AMITESH AGGARWAL
VENOUS THROMBOEMBOLISM DR. AMITESH AGGARWAL Pulmonary embolism and deep venous thrombosis spectrum of one disease venous thromboembolism PE is not a disease it is a complication of DVT 79% PE DVT LL 50%
More informationDr. Riaz JanMohamed Consultant Haematologist The Hillingdon Hospital Foundation Trust
MANAGEMENT OF PATIENTS WITH DEEP VEIN THROMBOSIS (DVT) IN THE COMMUNITY SETTING & ANTICOAGULATION CLINICS THE PAST, PRESENT AND THE FUTURE Dr. Riaz JanMohamed Consultant Haematologist The Hillingdon Hospital
More informationED Diagnosis of DVT or tools to rule out DVT in your ED
ED Diagnosis of DVT or tools to rule out DVT in your ED Ralph Wang UCSF Department of Emergency Medicine 53 yo f c/o left leg swelling recent cholecystectomy its midnight how do you manage this patient?
More informationDiagnosis and Treatment of Pulmonary Embolism. Farzin Ghiasi, MD Pulmonologist August, 2016
Diagnosis and Treatment of Pulmonary Embolism Farzin Ghiasi, MD Pulmonologist August, 2016 DVT & PE Hypercoagulable state is characteristic of pregnancy, and DVT occurs in about 1 in 500 pregnancies. In
More informationDOPPLER ULTRASOUND OF DEEP VENOUS THROMBOSIS
TOKUDA HOSPITAL SOFIA DOPPLER ULTRASOUND OF DEEP VENOUS THROMBOSIS MILENA STANEVA, MD, PhD Department of vascular surgery and angiology Venous thromboembolic disease continues to cause significant morbidity
More informationA 50-year-old woman with syncope
Hira Shahzad 1, Ali Bin Sarwar Zubairi 2 1 Medical College, Aga Khan University Hospital, Karachi 2 Department of Medicine, Aga Khan University Hospital, Karachi, Pakistan Ali Bin Sarwar Zubairi Associate
More informationMeissner MH, Gloviczki P, Comerota AJ, Dalsing MC, Eklof BG, Gillespie DL, et al. J Vasc Surg. 2012;55:
Early thrombus removal strategies for acute deep venous thrombosis: Clinical Practice Guidelines of the Society for Vascular Surgery and the American Venous Forum Meissner MH, Gloviczki P, Comerota AJ,
More informationPathology of pulmonary vascular disease. Dr.Ashraf Abdelfatah Deyab. Assistant Professor of Pathology Faculty of Medicine Almajma ah University
Pathology of pulmonary vascular disease Dr.Ashraf Abdelfatah Deyab Assistant Professor of Pathology Faculty of Medicine Almajma ah University Pulmonary vascular disease Type of pulmonary circulation: Types
More informationEpidermiology Early pulmonary embolism
Epidermiology Early pulmonary embolism Sitang Nirattisaikul Faculty of Medicine, Prince of Songkla University 3 rd most common cause of cardiovascular death in the United States, following ischemic heart
More informationA A U
PVD Venous AUC Rating Sheet 2nd Round 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 Median I NI MADM Rating Agree Disagree Upper Extremity Venous Evaluation Table 1. Venous Duplex of the Upper Extremities for Patency
More informationWhat You Should Know
1 New 2018 ASH Clinical Practice Guidelines on Venous Thromboembolism: What You Should Know New 2018 ASH Clinical Practice Guidelines on Venous Thromboembolism: What You Should Know The American Society
More informationVenous interventions in DVT
Venous interventions in DVT Sriram Narayanan Chief of Vascular and Endovascular Surgery, Tan Tock Seng Hospital A/Prof of Surgery, National University of Singapore ANTI-COAGULATION LMWH Warfarin x 6m Acute
More informationMDCT and Pulmonary Embolism. Heber MacMahon The University of Chicago Department of Radiology
MDCT and Pulmonary Embolism Heber MacMahon The University of Chicago Department of Radiology https://tinyurl.com/hmpe2018 Disclosures Consultant for Riverain Medical Minor stockholder in Hologic, Inc.
More informationAvoiding Pitfalls In PE
UC SF Avoiding Pitfalls In PE Jeffrey Tabas, MD Professor UCSF School of Medicine Emergency Department San Francisco General Hospital sf g h Disclosure No Financial Relationships to Disclose No significant
More informationAnticoagulation Forum: Management of Tiny Clots
Anticoagulation Forum: Management of Tiny Clots Casey O Connell, MD FACP Associate Professor Jane Anne Nohl Division of Hematology Keck School of Medicine USC DISCLOSURES None 4/11/2017 Objectives Define
More informationDEEP VENOUS THROMBOSIS A PRACTICAL APPROACH TO IMPROVING CLINICAL OUTCOMES
DEEP VENOUS THROMBOSIS A PRACTICAL APPROACH TO IMPROVING CLINICAL OUTCOMES Jose M. Borromeo M.D. Vascular Surgeon Iowa Heart Center Disclosures: AstraZeneca Pharmaceuticals Cook CVRx LeMaitre Vascular,
More information8/16/2012. Pulmonary Embolism
Pulmonary Embolism Rita M. Williams, NP-C, PA PeaceHealth Medical Group, Pulmonary & Critical Care Pulmonary Embolism Acute pulmonary embolism (PE) is a common and frequently fatal disease Clinical presentation
More informationNOTE: Deep Vein Thrombosis (DVT) Risk Factors
Deep Vein Thrombosis (DVT) Deep Vein Thrombosis (DVT) is the formation of a blood clot, known as a thrombus, in the deep leg vein. It is a very serious condition that can cause permanent damage to the
More informationIntended Learning Outcomes
2011 Acute Limb Ischemia Definition, Etiology & Pathophysiology Clinical Evaluation Management Ali SABBOUR Prof. of Vascular Surgery, Ain Shams University Acute Limb Ischemia Intended Learning Outcomes
More informationVASCULAR DISEASE: THREE THINGS YOU SHOULD KNOW JAMES A.M. SMITH, D.O. KANSAS VASCULAR MEDICINE, P.A. WICHITA, KANSAS
VASCULAR DISEASE: THREE THINGS YOU SHOULD KNOW JAMES A.M. SMITH, D.O. KANSAS VASCULAR MEDICINE, P.A. WICHITA, KANSAS KANSAS ASSOCIATION OF OSTEOPATHIC MEDICINE ANNUAL CME CONVENTION APRIL 13, 2018 THREE
More informationReducing the risk of venous thrombo-embolism (VTE) in hospital and after discharge
Reducing the risk of venous thrombo-embolism (VTE) in hospital and after discharge What is a venous thromboembolism (VTE)? This is a medical term that describes a blood clot that develops in a deep vein
More informationMisunderstandings of Venous thromboembolism prophylaxis
Misunderstandings of Venous thromboembolism prophylaxis Veerendra Chadachan Senior Consultant Dept of General Medicine (Vascular Medicine and Hypertension) Tan Tock Seng Hospital, Singapore Case scenario
More informationInterventional Treatment VTE: Radiologic Approach
Interventional Treatment VTE: Radiologic Approach Hae Giu Lee, MD Professor, Dept of Radiology Seoul St. Mary s Hospital The Catholic University of Korea Introduction Incidence High incidence: 250,000-1,000,000/year
More informationUltrasound-enhanced, catheter-directed thrombolysis for pulmonary embolism
NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE Interventional procedure consultation document Ultrasound-enhanced, catheter-directed thrombolysis for pulmonary embolism A pulmonary embolism (PE) is
More informationAnticoagulation for prevention of venous thromboembolism
Anticoagulation for prevention of venous thromboembolism Original article by: Michael Tam Note: updated in June 2009 with the eighth edition (from the seventh) evidence-based clinical practice guidelines
More informationThis chapter will describe the effectiveness of antithrombotic
Antithrombotic Therapy for Venous Thromboembolic Disease The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy Harry R. Büller, MD, Chair; Giancarlo Agnelli, MD; Russel D. Hull, MBBS,
More informationImplications from the ACCP 2012 Consensus Guidelines for the Management of Thrombosis: a case based approach
Implications from the ACCP 2012 Consensus Guidelines for the Management of Thrombosis: a case based approach Prof. I. Baumgartner Head Clinical and Interventional Angiology About the ACCP guidelines Widely
More informationInnovative Endovascular Approach to Pulmonary Embolism by Ultrasound Enhanced Thrombolysis. Prof. Ralf R.Kolvenbach MD,PhD,FEBVS
Innovative Endovascular Approach to Pulmonary Embolism by Ultrasound Enhanced Thrombolysis Prof. Ralf R.Kolvenbach MD,PhD,FEBVS Catheter-based thrombolysis Local administration of lytic agent Higher local
More informationPrevention and management of deep venous thrombosis (DVT) John Fletcher Wound Care Association of New South Wales
Prevention and management of deep venous thrombosis (DVT) John Fletcher Wound Care Association of New South Wales Merimbula, 6 th November 2010 University of Sydney Department of Surgery Westmead Hospital
More informationVenous Thromboembolism Prophylaxis
Approved by: Venous Thromboembolism Prophylaxis Vice President and Chief Medical Officer; and Vice President and Chief Operating Officer Corporate Policy & Procedures Manual Number: Date Approved January
More informationPulmonary embolism - the great masquerader
Pulmonary embolism - the great masquerader V.N. Karazin Kharkov National University Department of Internal Medicine Associate professor Makharynska О.S., MD, PhD 2016 Pulmonary embolism (PE) is a blockage
More informationRadiologic Features of The Pulmonary Embolus
January 2003 Radiologic Features of The Pulmonary Embolus Travis McGlothin HMSIII Mr. J is a 51 y.o. male who presented to the BIDMC ED w/ acute onset of: Lft. Hemiparesis slurred speech mild dyspnea mild
More informationDISORDERS OF VENOUS SYSTEM
DISORDERS OF VENOUS SYSTEM Varicose Veins Any dilated, elongated and tortuous vein irrespective of size Varicose veins are common in the superficial veins of the leg which are subject to high pressure
More informationDiagnostic Algorithms in VTE
Diagnostic Algorithms in VTE Mark H. Meissner, MD Department of Surgery University of Washington School of Medicine Overutilization of Venous Duplex U/S 1983-1993 (Zweibel et al, Australasian Rad, 1995)
More informationWith All the New Drugs, This is How I Treat Acute DVT and Superficial Phlebitis
BRIGHAM AND WOMEN S HOSPITAL With All the New Drugs, This is How I Treat Acute DVT and Superficial Phlebitis Gregory Piazza, MD, MS Division of Cardiovascular Medicine Brigham and Women s Hospital April
More informationNot all Leg DVT s are the Same: Which Patients Benefit from Interventional Therapy? Case 1:
12/16/2015 Not all Leg DVT s are the Same: Which Patients Benefit from Interventional Therapy? Constantino S.Peña, FSIR, FSCCT, FAHA Interventional Radiologist Medical Director, Vascular Imaging Miami
More informationDiagnosis and management of pulmonary embolism
Follow the link from the online version of this article to obtain certified continuing medical education credits bmj.com Respiratory Medicine updates from BMJ Group are at bmj.com/specialties/respiratory-medicine
More informationIs Thrombolysis Only for a Crisis?
Is Thrombolysis Only for a Crisis? December 19, 2017 Is Thrombolysis Only for a Crisis? Indications for Thrombolytic Therapy in Patients with Acute Pulmonary Embolism Case Scenario A 28 year old woman
More informationHandbook for Venous Thromboembolism
Handbook for Venous Thromboembolism Gregory Piazza Benjamin Hohlfelder Samuel Z. Goldhaber Handbook for Venous Thromboembolism Gregory Piazza Cardiovascular Division Harvard Medical School Brigham and
More informationINDICATIONS FOR THROMBO-PROPHYLAXIS AND WHEN TO STOP ANTICOAGULATION BEFORE ELECTIVE SURGERY
INDICATIONS FOR THROMBO-PROPHYLAXIS AND WHEN TO STOP ANTICOAGULATION BEFORE ELECTIVE SURGERY N.E. Pearce INTRODUCTION Preventable death Cause of morbidity and mortality Risk factors Pulmonary embolism
More informationPULMONARY EMBOLISM/VTE CARE PROCESS MODEL
PULMONARY EMBOLISM/VTE CARE PROCESS MODEL IMCP FALL CONFERENCE 2017 Scott Stevens, MD Co-Director, Thrombosis Clinic & Thrombosis Research Group Intermountain Medical Center Professor of Clinical Medicine
More informationVenous Thromboembolism (VTE)
Venous Thromboembolism (VTE) Nursing A guide for patients and carers Contents Why do blood clots form in veins?... 1 How common is a deep vein thrombosis (DVT) or pulmonary embolus (PE)?... 2 How are DVTs/
More informationPulmonary Embolism..Diagnostic Approach and Algorithm. Tolulope Adesiyun Harvard Medical School, Year III Gillian Lieberman, MD
Pulmonary Embolism..Diagnostic Approach and Algorithm Tolulope Adesiyun Harvard Medical School, Year III Gillian Lieberman, MD Epidemiology of Pulmonary Embolism Pulmonary Embolus (PE): Thrombus originating
More informationHow long to continue anticoagulation after DVT?
How long to continue anticoagulation after DVT? Dr. Nihar Ranjan Pradhan M.S., DNB (Vascular Surgery), FVES(UK) Consultant Vascular Surgeon Apollo Hospital, Jubilee Hills, Hyderabad (Formerly Faculty in
More informationUniversity Journal of Medicine and Medical Specialities
University Journal of Medicine and Medical Specialities Volume 1 Issue 1 2015 An unusual case of SADDLE Pulmonary Thrombo Embolism Boopathirajan P Jayanthi R Stanley Medical College Abstract: Pulmonary
More informationThe Johns Hopkins Hospital Patient Information. How Do I Prevent Blood Clots? Venous Thromboembolism (VTE) Deep Vein Thrombosis (DVT)
Page 1 of 11 Venous Thromboembolism () What is a clot or Venous Thromboembolism ()? Blood clots are called Venous Thromboembolism (). There are 2 main types: is a clot in a deep vein, usually an arm or
More informationSupplementary material 1. Definitions of study endpoints (extracted from the Endpoint Validation Committee Charter) 1.
Rationale, design, and baseline characteristics of the SIGNIFY trial: a randomized, double-blind, placebo-controlled trial of ivabradine in patients with stable coronary artery disease without clinical
More informationDiagnosis and management of acute pulmonary embolism Bobbie Morici, MSPAS, PA-C
Diagnosis and management of acute pulmonary embolism Bobbie Morici, MSPAS, PA-C ABSTRACT Acute pulmonary embolism is a life-threatening diagnosis that can present with a multitude of nonspecific symptoms.
More informationMassive and Submassive Pulmonary Embolism: 2017 Update and Future Directions
Massive and Submassive Pulmonary Embolism: 2017 Update and Future Directions Kush R Desai, MD Assistant Professor of Radiology Northwestern University Feinberg School of Medicine Chicago, IL Disclosures
More informationEmerg Med Clin N Am 26 (2008) Venothromboembolism. J. Matthew Fields, MD, Munish Goyal, MD, FACEP*
Emerg Med Clin N Am 26 (2008) 649 683 Venothromboembolism J. Matthew Fields, MD, Munish Goyal, MD, FACEP* Department of Emergency Medicine, University of Pennsylvania School of Medicine, 3400 Spruce Street,
More informationProblems with Cardiac and Tissue Perfusion
Problems with Cardiac and Tissue Perfusion Review anatomy and physiology Identify ECG Echocardiogram TEE Persantine Thallium Coronary angiogram Discuss etiology, pathophsiology, clinical manifestation,
More informationInferior Vena Cava Filter for DVT
Inferior Vena Cava Filter for DVT Deep Vein Thrombosis A deep vein thrombosis (DVT) is a blood clot that forms in a deep vein. This is a serious condition that occurs more often than you might think. If
More informationChapter 1. Introduction
Chapter 1 Introduction Introduction 9 Even though the first reports on venous thromboembolism date back to the 13 th century and the mechanism of acute pulmonary embolism (PE) was unraveled almost 150
More informationOVERVIEW ACUTE CORONARY SYNDROME SYMPTOMS 9/30/14 TYPICAL WHAT IS ACUTE CORONARY SYNDROME? SYMPTOMS, IDENTIFICATION, MANAGEMENT
OVERVIEW ACUTE CORONARY SYNDROME SYMPTOMS, IDENTIFICATION, MANAGEMENT OCTOBER 7, 2014 PETE PERAUD, MD SYMPTOMS TYPICAL ATYPICAL IDENTIFICATION EKG CARDIAC BIOMARKERS STEMI VS NON-STEMI VS USA MANAGEMENT
More information